Similar articles

• Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria.

  Phillips JD, Steensma DP, Pulsipher MA, Spangrude GJ, Kushner JP. Phillips JD, et al. Blood. 2007 Mar 15;109(6):2618-21. doi: 10.1182/blood-2006-06-022848. Epub 2006 Dec 5. Blood. 2007. PMID: 17148589 Free PMC article.
• Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis.

  Di Pierro E, Russo R, Karakas Z, Brancaleoni V, Gambale A, Kurt I, Winter SS, Granata F, Czuchlewski DR, Langella C, Iolascon A, Cappellini MD. Di Pierro E, et al. Eur J Haematol. 2015 Jun;94(6):491-7. doi: 10.1111/ejh.12452. Epub 2014 Oct 25. Eur J Haematol. 2015. PMID: 25251786
• Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.

  Martinez Peinado C, Díaz de Heredia C, To-Figueras J, Arias-Santiago S, Nogueras P, Elorza I, Olivé T, Bádenas C, Moreno MJ, Tercedor J, Herrero C. Martinez Peinado C, et al. Pediatr Dermatol. 2013 Jul-Aug;30(4):484-9. doi: 10.1111/pde.12117. Epub 2013 Apr 5. Pediatr Dermatol. 2013. PMID: 23557135
• Congenital erythropoietic porphyria: advances in pathogenesis and treatment.

  Desnick RJ, Astrin KH. Desnick RJ, et al. Br J Haematol. 2002 Jun;117(4):779-95. doi: 10.1046/j.1365-2141.2002.03557.x. Br J Haematol. 2002. PMID: 12060112 Review. No abstract available.
• Congenital erythropoietic porphyria: Recent advances.

  Erwin AL, Desnick RJ. Erwin AL, et al. Mol Genet Metab. 2019 Nov;128(3):288-297. doi: 10.1016/j.ymgme.2018.12.008. Epub 2018 Dec 27. Mol Genet Metab. 2019. PMID: 30685241 Free PMC article. Review.